Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

被引：0
|
作者：
Makoto Araie
Kazuhisa Sugiyama
Kenji Aso
Koji Kanemoto
Kalyani Kothapalli
Casey Kopczynski
Michelle Senchyna
David A. Hollander
机构：
[1] Kanto Central Hospital of the Mutual Aid Association of Public School Teachers,Department of Ophthalmology
[2] Kanazawa University Graduate School of Medical Science,undefined
[3] Aerie Pharmaceuticals Ireland Ltd. (Japan Branch),undefined
[4] Statistics and Data Corporation,undefined
[5] Aerie Pharmaceuticals,undefined
[6] Inc.,undefined
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
Conjunctival hyperemia; Glaucoma; Intraocular pressure; Netarsudil; Rho-associated protein kinase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1757 / 1775
页数：18
相关论文
共 50 条
  • [41] Randomized, Controlled, Phase 3 Trials of Carteolol/Latanoprost Fixed Combination in Primary Open-Angle Glaucoma or Ocular Hypertension
    Yamamoto, Tetsuya
    Ikegami, Toru
    Ishikawa, Yuji
    Kikuchi, Satoru
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 171 : 35 - 46
  • [42] Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice
    Pillunat, Lutz E.
    Eschstruth, Peter
    Haesemeyer, Stefan
    Thelen, Ulrich
    Foja, Christian
    Leaback, Richard
    Pfennigsdorf, Stefan
    CLINICAL OPHTHALMOLOGY, 2016, 10 : 1759 - 1765
  • [43] Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and-2
    Asrani, Sanjay
    Bacharach, Jason
    Holland, Edward
    McKee, Hayley
    Sheng, Huan
    Lewis, Richard A.
    Kopczynski, Casey C.
    Heah, Theresa
    ADVANCES IN THERAPY, 2020, 37 (04) : 1620 - 1631
  • [44] Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study
    Aihara, Makoto
    Lu, Fenghe
    Kawata, Hisashi
    Iwata, Akihiro
    Odani-Kawabata, Noriko
    Shams, Naveed K.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2020, 220 : 53 - 63
  • [45] Bimatoprost 0.01 % for previously treated patients with open-angle glaucoma or ocular hypertension in the Korean clinical setting
    Kook, Michael Scott
    Simonyi, Susan
    Sohn, Yong Ho
    Kim, Chan Yun
    Park, Ki Ho
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2015, 59 (05) : 325 - 334
  • [46] Efficacy of corneal shape index in the evaluation of ocular hypertension, primary open-angle glaucoma and exfoliative glaucoma
    Vieira, Maria J.
    Pereira, Joana
    Castro, Miguel
    Arruda, Henrique
    Martins, Joana
    Sousa, Joao Paulo
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2022, 32 (01) : 275 - 281
  • [47] Brinzolamide/TimololIn Open-Angle Glaucoma and Ocular Hypertension
    Jamie D. Croxtall
    Lesley J. Scott
    Drugs & Aging, 2009, 26 : 437 - 446
  • [48] Travoprost in the management of open-angle glaucoma and ocular hypertension
    Denis, Philippe
    Covert, David
    Realini, Anthony
    CLINICAL OPHTHALMOLOGY, 2007, 1 (01): : 11 - 24
  • [49] Is primary open-angle glaucoma an ocular manifestation of systemic disease?
    Wey, Stephanie
    Amanullah, Sarah
    Spaeth, George L.
    Ustaoglu, Melih
    Rahmatnejad, Kamran
    Katz, L. Jay
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (04) : 665 - 673
  • [50] Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
    Sun, Xinghuai
    Yao, Ke
    Liu, Qinghuai
    Zhang, Hong
    Xing, Xiaoli
    Fang, Aiwu
    Duan, Xuanchu
    Yu, Minbin
    Chen, Michelle Y.
    Yang, Jingyuan
    Goodkin, Margot L.
    OPHTHALMOLOGY AND THERAPY, 2023, 12 (01) : 341 - 353
12345